The importance of neutrophil-to-lymphocyte ratio before and after radiation in breast cancer patients

[1] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166 SiegelR NaishadhamD JemalA Cancer statistics, 2013 CA Cancer J Clin 2013 63 1 11 30 10.3322/caac.21166 Open DOISearch in Google Scholar

[2] Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237–249. doi:10.1053/j.seminoncol.2009.03.001 AndersCK JohnsonR LittonJ PhillipsM BleyerA Breast cancer before age 40 years Semin Oncol 2009 36 3 237 249 10.1053/j.seminoncol.2009.03.001 Open DOISearch in Google Scholar

[3] Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis. 2013;5 Suppl 1(Suppl 1):S2–8. doi:10.3978/j.issn.2072-1439.2013.05.24 AssiHA KhouryKE DboukH KhalilLE MouhieddineTH El SaghirNS Epidemiology and prognosis of breast cancer in young women J Thorac Dis 2013 5 Suppl 1(Suppl 1) S2 8 10.3978/j.issn.2072-1439.2013.05.24 Open DOISearch in Google Scholar

[4] DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62. doi:10.3322/caac.21203 DeSantisC MaJ BryanL JemalA Breast cancer statistics, 2013 CA Cancer J Clin 2014 64 1 52 62 10.3322/caac.21203 Open DOISearch in Google Scholar

[5] Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res BCR. 2010;12(5):212. doi:10.1186/bcr2647 GabrielCA DomchekSM Breast cancer in young women Breast Cancer Res BCR 2010 15 5 212 10.1186/bcr2647 Open DOISearch in Google Scholar

[6] Ferguson NL, Bell J, Heidel R, et al. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Breast J. 2013;19(1):22–30. doi:10.1111/tbj.12059 FergusonNL BellJ HeidelR Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women Breast J 2013 19 1 22 30 10.1111/tbj.12059 Open DOISearch in Google Scholar

[7] Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther. 2010;87(4):401–406. doi:10.1038/clpt.2009.312 BalkwillF MantovaniA Cancer and inflammation: implications for pharmacology and therapeutics Clin Pharmacol Ther 2010 87 4 401 406 10.1038/clpt.2009.312 Open DOISearch in Google Scholar

[8] Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230. doi:10.1016/j.critrevonc.2013.03.010 GuthrieGJK CharlesKA RoxburghCSD HorganPG McMillanDC ClarkeSJ The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 2013 88 1 218 230 10.1016/j.critrevonc.2013.03.010 Open DOISearch in Google Scholar

[9] Yao M, Liu Y, Jin H, et al. Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer. OncoTargets Ther. 2014;7:1743–1752. doi:10.2147/OTT.S69657 YaoM LiuY JinH Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer OncoTargets Ther 2014 7 1743 1752 10.2147/OTT.S69657 Open DOISearch in Google Scholar

[10] Satelli A, Brownlee Z, Mitra A, Meng QH, Li S. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response. Clin Chem. 2015;61(1):259–266. doi:10.1373/clinchem.2014.228122 SatelliA BrownleeZ MitraA MengQH LiS Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response Clin Chem 2015 61 1 259 266 10.1373/clinchem.2014.228122 Open DOISearch in Google Scholar

[11] Fentiman IS, Allen DS. γ-Glutamyl transferase and breast cancer risk. Br J Cancer. 2010;103(1):90–93. doi:10.1038/sj.bjc.6605719 FentimanIS AllenDS γ-Glutamyl transferase and breast cancer risk Br J Cancer 2010 103 1 90 93 10.1038/sj.bjc.6605719 Open DOISearch in Google Scholar

[12] Forget P, Machiels JP, Coulie PG, et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol. 2013;20 Suppl 3:S650–660. doi:10.1245/s10434-013-3136-x ForgetP MachielsJP CouliePG Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery Ann Surg Oncol 2013 20 Suppl 3 S650 660 10.1245/s10434-013-3136-x Open DOISearch in Google Scholar

[13] Hung HY, Chen JS, Yeh CY, et al. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis. 2011;26(8):1059–1065. doi:10.1007/s00384-011-1192-x HungHY ChenJS YehCY Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy Int J Colorectal Dis 2011 26 8 1059 1065 10.1007/s00384-011-1192-x Open DOISearch in Google Scholar

[14] Keizman D, Gottfried M, Ish-Shalom M, et al. Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram. The Oncologist. 2012;17(12):1508–1514. doi:10.1634/theoncologist.2012-0125 KeizmanD GottfriedM Ish-ShalomM Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram The Oncologist 2012 17 12 1508 1514 10.1634/theoncologist.2012-0125 Open DOISearch in Google Scholar

[15] Mallappa S, Sinha A, Gupta S, Chadwick SJD. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2013;15(3):323–328. doi:10.1111/codi.12008 MallappaS SinhaA GuptaS ChadwickSJD Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer Colorectal Dis Off J Assoc Coloproctology G B Irel 2013 15 3 323 328 10.1111/codi.12008 Open DOISearch in Google Scholar

[16] Sharaiha RZ, Halazun KJ, Mirza F, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol. 2011;18(12):3362–3369. doi:10.1245/s10434-011-1754-8 SharaihaRZ HalazunKJ MirzaF Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer Ann Surg Oncol 2011 18 12 3362 3369 10.1245/s10434-011-1754-8 Open DOISearch in Google Scholar

[17] Tomita M, Shimizu T, Ayabe T, Nakamura K, Onitsuka T. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer Res. 2012;32(8):3535–3538. TomitaM ShimizuT AyabeT NakamuraK OnitsukaT Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer Anticancer Res 2012 32 8 3535 3538 Search in Google Scholar

[18] Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19(1):217–224. doi:10.1245/s10434-011-1814-0 AzabB BhattVR PhookanJ Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients Ann Surg Oncol 2012 19 1 217 224 10.1245/s10434-011-1814-0 Open DOISearch in Google Scholar

[19] Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer. 2013;16(1):55–59. doi:10.4048/jbc.2013.16.1.55 NohH EommM HanA Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients J Breast Cancer 2013 16 1 55 59 10.4048/jbc.2013.16.1.55 Open DOISearch in Google Scholar

[20] Corbeau I, Jacot W, Guiu S. Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review. Cancers. 2020;12(4):958. doi:10.3390/cancers12040958 CorbeauI JacotW GuiuS Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review Cancers 2020 15 4 958 10.3390/cancers12040958 Open DOISearch in Google Scholar

[21] Forget P, Bentin C, Machiels JP, Berliere M, Coulie PG, De Kock M. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br J Anaesth. 2014;113 Suppl 1:i82–87. doi:10.1093/bja/aet464 ForgetP BentinC MachielsJP BerliereM CouliePG De KockM Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery Br J Anaesth 2014 113 Suppl 1 i82 87 10.1093/bja/aet464 Open DOISearch in Google Scholar

[22] Dirican A, Kucukzeybek BB, Alacacioglu A, et al. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2015;20(1):70–81. doi:10.1007/s10147-014-0672-8 DiricanA KucukzeybekBB AlacaciogluA Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol 2015 20 1 70 81 10.1007/s10147-014-0672-8 Open DOISearch in Google Scholar

[23] Grassadonia A, Graziano V, Iezzi L, et al. Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting. Cells. 2021;10(7):1685. doi:10.3390/cells10071685 GrassadoniaA GrazianoV IezziL Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting Cells 2021 10 7 1685 10.3390/cells10071685 Open DOISearch in Google Scholar

[24] Neofytou K, Smyth EC, Giakoustidis A, Khan AZ, Cunningham D, Mudan S. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Med Oncol Northwood Lond Engl. 2014;31(10):239. doi:10.1007/s12032-014-0239-6 NeofytouK SmythEC GiakoustidisA KhanAZ CunninghamD MudanS Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor Med Oncol Northwood Lond Engl 2014 31 10 239 10.1007/s12032-014-0239-6 Open DOISearch in Google Scholar

[25] Cihan YB, Arslan A, Cetindag MF, Mutlu H. Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer. Asian Pac J Cancer Prev APJCP. 2014;15(10):4225–4231. doi:10.7314/apjcp.2014.15.10.4225 CihanYB ArslanA CetindagMF MutluH Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer Asian Pac J Cancer Prev APJCP 2014 15 10 4225 4231 10.7314/apjcp.2014.15.10.4225 Open DOISearch in Google Scholar

[26] Zhou Q, Dong J, Sun Q, Lu N, Pan Y, Han X. Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis. BMJ Open. 2021;11(9):e047957. doi:10.1136/bmjopen-2020-047957 ZhouQ DongJ SunQ LuN PanY HanX Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: a meta-analysis BMJ Open 2021 11 9 e047957 10.1136/bmjopen-2020-047957 Open DOISearch in Google Scholar

[27] Shinko D, Diakos CI, Clarke SJ, Charles KA. Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine. Clin Pharmacol Ther. 2017;102(4):599–610. doi:10.1002/cpt.789 ShinkoD DiakosCI ClarkeSJ CharlesKA Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine Clin Pharmacol Ther 2017 102 4 599 610 10.1002/cpt.789 Open DOISearch in Google Scholar

[28] McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.003 McMillanDC The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer Cancer Treat Rev 2013 39 5 534 540 10.1016/j.ctrv.2012.08.003 Open DOISearch in Google Scholar

[29] Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-3 DiakosCI CharlesKA McMillanDC ClarkeSJ Cancer-related inflammation and treatment effectiveness Lancet Oncol 2014 15 11 e493 503 10.1016/S1470-2045(14)70263-3 Open DOISearch in Google Scholar

[30] Mizuno R, Kawada K, Itatani Y, Ogawa R, Kiyasu Y, Sakai Y. The Role of Tumor-Associated Neutrophils in Colorectal Cancer. Int J Mol Sci. 2019;20(3):529. doi:10.3390/ijms20030529 MizunoR KawadaK ItataniY OgawaR KiyasuY SakaiY The Role of Tumor-Associated Neutrophils in Colorectal Cancer Int J Mol Sci 2019 20 3 529 10.3390/ijms20030529 Open DOISearch in Google Scholar

[31] Yang L, Huang Y, Zhou L, Dai Y, Hu G. High pre-treatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Head Neck. 2019;41(5):1525–1535. doi:10.1002/hed.25583 YangL HuangY ZhouL DaiY HuG High pre-treatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis Head Neck 2019 41 5 1525 1535 10.1002/hed.25583 Open DOISearch in Google Scholar

[32] Liu G, Ke LC, Sun SR. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis. Medicine (Baltimore). 2018;97(36):e12176. doi:10.1097/MD.0000000000012176 LiuG KeLC SunSR Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis Medicine (Baltimore) 2018 97 36 e12176 10.1097/MD.0000000000012176 Open DOISearch in Google Scholar

[33] Vartolomei MD, Porav-Hodade D, Ferro M, et al. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis. Urol Oncol. 2018;36(9):389–399. doi:10.1016/j.urolonc.2018.05.014 VartolomeiMD Porav-HodadeD FerroM Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis Urol Oncol 2018 36 9 389 399 10.1016/j.urolonc.2018.05.014 Open DOISearch in Google Scholar

[34] Huang QT, Zhou L, Zeng WJ, et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2017;41(6):2411–2418. doi:10.1159/000475911 HuangQT ZhouL ZengWJ Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 2017 41 6 2411 2418 10.1159/000475911 Open DOISearch in Google Scholar

[35] Bowen RC, Little NAB, Harmer JR, et al. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(19):32171–32189. doi:10.18632/oncotarget.16291 BowenRC LittleNAB HarmerJR Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis Oncotarget 2017 8 19 32171 32189 10.18632/oncotarget.16291 Open DOISearch in Google Scholar

[36] Tang H, Lu W, Li B, Li C, Xu Y, Dong J. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(22):36857–36868. doi:10.18632/oncotarget.16143 TangH LuW LiB LiC XuY DongJ Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis Oncotarget 2017 8 22 36857 36868 10.18632/oncotarget.16143 Open DOISearch in Google Scholar

[37] Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell. 2009;16(3):183–194. doi:10.1016/j.ccr.2009.06.017 FridlenderZG SunJ KimS Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN Cancer Cell 2009 16 3 183 194 10.1016/j.ccr.2009.06.017 Open DOISearch in Google Scholar

[38] Bodogai M, Moritoh K, Lee-Chang C, et al. Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. Cancer Res. 2015;75(17):3456–3465. doi:10.1158/0008-5472.CAN-14-3077 BodogaiM MoritohK Lee-ChangC Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells Cancer Res 2015 75 17 3456 3465 10.1158/0008-5472.CAN-14-3077 Open DOISearch in Google Scholar

[39] Liu W, Ha M, Yin N. Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer. Oncotarget. 2017;8(42):73198–73207. doi:10.18632/oncotarget.18336 LiuW HaM YinN Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer Oncotarget 2017 8 42 73198 73207 10.18632/oncotarget.18336 Open DOISearch in Google Scholar

[40] Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Biol. 2013;23(3):141–148. doi:10.1016/j.semcancer.2013.02.005 DumitruCA LangS BrandauS Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression Semin Cancer Biol 2013 23 3 141 148 10.1016/j.semcancer.2013.02.005 Open DOISearch in Google Scholar

[41] Nakamura N, Kusunoki Y, Akiyama M. Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay. Radiat Res. 1990;123(2):224–227. NakamuraN KusunokiY AkiyamaM Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay Radiat Res 1990 123 2 224 227 Search in Google Scholar

[42] Kuhn E, Gambini D, Despini L, Asnaghi D, Runza L, Ferrero S. Updates on Lymphovascular Invasion in Breast Cancer. Biomedicines. 2023;11(3):968. doi:10.3390/biomedicines11030968 KuhnE GambiniD DespiniL AsnaghiD RunzaL FerreroS Updates on Lymphovascular Invasion in Breast Cancer Biomedicines 2023 11 3 968 10.3390/biomedicines11030968 Open DOISearch in Google Scholar